Your browser doesn't support javascript.
loading
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
Tenforde, Mark W; Gupte, Nikhil; Dowdy, David W; Asmuth, David M; Balagopal, Ashwin; Pollard, Richard B; Sugandhavesa, Patcharaphan; Lama, Javier R; Pillay, Sandy; Cardoso, Sandra W; Pawar, Jyoti; Santos, Breno; Riviere, Cynthia; Mwelase, Noluthando; Kanyama, Cecilia; Kumwenda, Johnstone; Hakim, James G; Kumarasamy, Nagalingeswaran; Bollinger, Robert; Semba, Richard D; Campbell, Thomas B; Gupta, Amita.
Afiliação
  • Tenforde MW; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Gupte N; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Dowdy DW; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Asmuth DM; University of California Davis Medical Center, Sacramento, California, United States of America.
  • Balagopal A; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Pollard RB; University of California Davis Medical Center, Sacramento, California, United States of America.
  • Sugandhavesa P; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Lama JR; Asociación Civil Impacta Salud y Educación (IMPACTA) Peru Clinical Trials Unit, Lima, Peru.
  • Pillay S; Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Cardoso SW; Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Pawar J; National AIDS Research Institute, Pune, India.
  • Santos B; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
  • Riviere C; Les Centres Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunites (GHESKIO), Port-Au-Prince, Haiti.
  • Mwelase N; University of Witwatersrand, Johannesburg, South Africa.
  • Kanyama C; University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi.
  • Kumwenda J; Malawi College of Medicine-Johns Hopkins University Research Project, Blantyre, Malawi.
  • Hakim JG; University of Zimbabwe, Harare, Zimbabwe.
  • Kumarasamy N; Y.R. Gaitonde Centre for AIDS Research and Education (YRG CARE), Chennai, India.
  • Bollinger R; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Semba RD; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Campbell TB; University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America.
  • Gupta A; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
PLoS One ; 10(2): e0117424, 2015.
Article em En | MEDLINE | ID: mdl-25719208

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Proteína C-Reativa / Lipopolissacarídeos / Infecções Oportunistas Relacionadas com a AIDS / Antirretrovirais / Quimiocina CXCL10 Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Proteína C-Reativa / Lipopolissacarídeos / Infecções Oportunistas Relacionadas com a AIDS / Antirretrovirais / Quimiocina CXCL10 Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos